![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMGWP RNS Number : 4120U GW Pharmaceuticals PLC 24 June 2009 24 June 2009 GW Pharmaceuticals plc ("GW" or "the Company") SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS The Company has been notified that, on 23rd June 2009, Dr Geoffrey Guy, a Director of the Company, transferred 459,324 ordinary shares of 0.1p to his personal pension scheme. The transfer amounts to 0.38% of the issued ordinary share capital. Following this notification Dr Guy's beneficial interest remains unchanged at 19,856,063 ordinary shares, amounting to 16.4% of the shares in issue. Enquiries: GW Pharmaceuticals plc 01980 557000 Adam George, Company Secretary Nominated Adviser 0207 5975970 Patrick Robb, Investec Bank plc This information is provided by RNS The company news service from the London Stock Exchange END RDSIIFLTRAISFIA
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions